An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
NCT00776659 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 39
Last updated 2013-11-19
Summary
To generate the following data from patients with early breast cancer treated with Aromasin® in the adjuvant setting in India.
* Efficacy of the treatment with Aromasin®
* Safety of the treatment with Aromasin®
Conditions
- Breast Neoplasms
Interventions
- OTHER
-
Aromasin
Non-Interventional study design.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- India
Study Locations
More Related Trials
-
A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
NCT01305239 ·Status: TERMINATED
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer
NCT00143390 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer
NCT00544986 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
NCT01080170 ·Status: COMPLETED
-
Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women
NCT00040014 ·Status: TERMINATED ·Phase: PHASE2
-
Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg
NCT00859560 ·Status: COMPLETED
-
Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients
NCT00174343 ·Status: COMPLETED ·Phase: PHASE2
-
Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)
NCT01050634 ·Status: COMPLETED
-
Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
NCT00066586 ·Status: COMPLETED ·Phase: NA
-
Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
NCT00038103 ·Status: COMPLETED ·Phase: PHASE2
-
Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study
NCT00653718 ·Status: COMPLETED
-
Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
NCT01954706 ·Status: TERMINATED ·Phase: NA
-
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
NCT00065325 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer
NCT00649090 ·Status: COMPLETED ·Phase: PHASE4
-
Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy
NCT00784888 ·Status: COMPLETED
-
An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice
NCT00767585 ·Status: COMPLETED
-
Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients
NCT00727883 ·Status: COMPLETED
-
Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor
NCT01765049 ·Status: ACTIVE_NOT_RECRUITING
-
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
NCT00562458 ·Status: COMPLETED
-
Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
NCT05700006 ·Status: COMPLETED
-
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
NCT05103644 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
NCT01693731 ·Status: COMPLETED
-
Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer
NCT00279448 ·Status: COMPLETED ·Phase: PHASE3
-
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
NCT00542594 ·Status: TERMINATED